NEURAXIS, INC. (NRXS) Current Ratio
- Current ratio · latest quarter: Value 3.04×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.04× | Current assets / current liabilities. $9.41M ÷ $3.10M ≈ 3.04× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 9.41M USD | Assets, Current |
| Current obligations | 3.10M USD | Liabilities, Current |
| Cash and equivalents | 8.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 432.93K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 277.31K USD | Inventory, Net |
| Payables | 791.59K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.41M | $3.10M | $8.32M | (m) | $432.93K | $277.31K | $791.59K | (m) | 3.04× |
| 2026-03-31 | $8.14M | $2.81M | $7.08M | (m) | $385.01K | $238.28K | $305.30K | (m) | 2.89× |
| 2025-12-31 | $5.73M | $2.79M | $4.97M | (m) | $195.70K | $257.13K | $139.37K | (m) | 2.05× |
| 2025-09-30 | $4.99M | $3.15M | $4.38M | (m) | $108.50K | $110.26K | $886.40K | (m) | 1.58× |
| 2025-06-30 | $6.62M | $2.35M | $5.99M | (m) | $128.52K | $131.43K | $464.52K | (m) | 2.82× |
| 2025-03-31 | $2.54M | $2.10M | $2.01M | (m) | $243.71K | $37.42K | $535.02K | (m) | 1.21× |
| 2024-12-31 | $4.27M | $2.43M | $3.70M | (m) | $244.62K | $44.33K | $596.95K | (m) | 1.75× |
| 2024-09-30 | $631.84K | $2.66M | $260.88K | (m) | $52.59K | $22.46K | $962.11K | (m) | 0.24× |
| 2024-06-30 | $2.11M | $7.59M | $1.77M | (m) | $147.13K | $42.71K | $1.12M | (m) | 0.28× |
| 2024-03-31 | $407.83K | $3.82M | $81.75K | (m) | $90.53K | $20.19K | $1.24M | (m) | 0.11× |
| 2023-12-31 | $242.61K | $1.89M | $78.56K | (m) | $73.17K | $21.22K | $1.20M | (m) | 0.13× |
| 2023-09-30 | $966.85K | $2.26M | $761.25K | (m) | $132.38K | $34.53K | $566.65K | (m) | 0.43× |
| 2023-06-30 | $354.15K | $11.43M | $51.44K | (m) | $237.17K | $44.20K | $2.44M | (m) | 0.03× |
| 2022-12-31 | $476.96K | $6.98M | $253.70K | (m) | $174.40K | $48.13K | $1.59M | (m) | 0.07× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |